Pharmacological aspects of the enzastaurin-pemetrexed combination in Non-Small Cell Lung Cancer (NSCLC).
Current Drug Targets.
Times cited: 12
A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.
Clinical Cancer Research.
Times cited: 64
Endothelial dysfunction in antiangiogenesis-associated thrombosis  (multiple letters).
Journal of Clinical Oncology.
Times cited: 22